It has been found that the M1 phenotype is acquired after being stimulated with pro-inflammatory factors, such as Toll-like receptor 4 (TLR-4) ligands and interferon-gamma (IFN-γ), and then eliminates tumor cells by producing inflammatory factors (e.g., TNF-a) [39,40]. The gene discussed is TLR4; the disease is neoplasm.